Kolasa Agnieszka
Katedra i Zakład Histologii i Embriologii Pomorskiej Akademii Medycznej, Szczecin.
Ann Acad Med Stetin. 2006;52(2):13-21; discussion 21.
The aim of this study was to determine the effect of reduced availability of dihydrotestosterone (DHT) on the expression of estrogen receptors alpha and beta (ERalpha and ERbeta) in the epididymis in vivo and in vitro. Expression of estrogen receptors (ERs) is interesting because of the fact that the male reproductive system is controlled not only by androgens but also, in a far-reaching and complex manner, by estrogens. Control by estrogens is exercised through activation of ERs widely distributed in the epididymal epithelium. Epididymal epithelial cells contain a 5alpha-reductase (5alpha-red) which catalyzes the irreversible conversion of testosterone (T) into the most potent and chief androgen of the epididymis, dihydrotestosterone, known to maintain and regulate the structure and functions of the epididymis. Two isoforms of the 5alpha-red were identified: type 1 (5alpha-redl) and type 2 (5alpha-red2). 5alpha-reductase type 2 is more widely expressed in the epididymis than 5alpha-redl. DHT deficit was produced by inhibition of 5alpha-red2 using finasteride (Proscar, MSD Sweden), a steroid inhibitor of this enzyme.
The study was performed in the adult, male Wistar rats randomly divided into control (K) and study (Fin56) groups (5 animals in each). Animals in the study group received 5mg finasteride/kg b.w., orally during 56 days (duration of one spermatogenesis). Immunoexpression of ERs was also studied in epididymal epithelial cells cultured with or without finasteride.
It was shown that DHT deficiency, both in vivo and in vitro condition, modulated ERs expression in comparison to the epididymis from control rats and to epididymal cells cultured without finasteride. Distribution of ERalpha and ERbeta in epididymal cells changed (from nucleus to cytoplasm) and the level of ERs expression was markedly decreased.
The present findings show that the DHT deficiency caused by finasteride altered the expression of ERalpha and ERbeta in the epididymis and possibly may have destabilized the functioning of this organ.
本研究的目的是确定二氢睾酮(DHT)可用性降低对体内和体外附睾中雌激素受体α和β(ERα和ERβ)表达的影响。雌激素受体(ERs)的表达很有趣,因为男性生殖系统不仅受雄激素控制,还以深远而复杂的方式受雌激素控制。雌激素通过激活广泛分布于附睾上皮中的ERs来发挥控制作用。附睾上皮细胞含有5α-还原酶(5α-red),它催化睾酮(T)不可逆地转化为附睾中最有效和主要的雄激素二氢睾酮,已知其可维持和调节附睾的结构与功能。已鉴定出5α-还原酶的两种同工型:1型(5α-red1)和2型(5α-red2)。5α-还原酶2型在附睾中的表达比5α-red1更广泛。使用非那雄胺(保列治,默克雪兰诺瑞典公司)抑制5α-还原酶2型来产生DHT缺乏,非那雄胺是该酶的一种甾体抑制剂。
本研究在成年雄性Wistar大鼠中进行,随机分为对照组(K)和研究组(Fin56)(每组5只动物)。研究组动物在56天(一个精子发生周期)内口服5mg非那雄胺/千克体重。还研究了在有或无非那雄胺培养的附睾上皮细胞中ERs的免疫表达。
结果表明,与对照大鼠的附睾以及无非那雄胺培养的附睾细胞相比,体内和体外条件下的DHT缺乏均调节了ERs的表达。附睾细胞中ERα和ERβ的分布发生了变化(从细胞核到细胞质),且ERs的表达水平显著降低。
目前的研究结果表明,非那雄胺导致的DHT缺乏改变了附睾中ERα和ERβ的表达,可能使该器官的功能不稳定。